Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart J D Neil

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 16, 2023
The ongoing Streptococcus pyogenes (Group A Streptococcus) outbreak in London, United Kingdom, in December 2022: a molecular epidemiology studyAdela Alcolea-Medina, Luke B Snell, Christopher Alder, et al.
Cell Reports|April 29, 2026
The long isoform of ZAP coordinates multiple enzymes to mediate complete decay of target transcriptsClément R Bouton, Grega Gimpelj Domjanič, María José Lista, et al.
Journal of Virology|November 9, 2022
The P681H Mutation in the Spike Glycoprotein of the Alpha Variant of SARS-CoV-2 Escapes IFITM Restriction and Is Necessary for Type I Interferon ResistanceMaria Jose Lista, Helena Winstone, Harry D Wilson, et al.
Nature Communications|December 31, 2024
Antibodies to the RBD of SARS-CoV-2 spike mediate productive infection of primary human macrophagesSuzanne Pickering, Harry Wilson, Enrico Bravo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2022
Real-Time Whole Genome Sequencing to Guide Patient-Tailored Therapy of Severe Acute Respiratory Syndrome Coronavirus 2 InfectionLuke B Snell, Adela Alcolea-Medina, Themoula Charalampous, et al.
Mbio|June 20, 2019
Upregulation of BST-2 by Type I Interferons Reduces the Capacity of Vpu To Protect HIV-1-Infected Cells from NK Cell ResponsesJérémie Prévost, Suzanne Pickering, Mitchell J Mumby, et al.
Plos One|April 7, 2021
Clinical utility of targeted SARS-CoV-2 serology testing to aid the diagnosis and management of suspected missed, late or post-COVID-19 infection syndromes: Results from a pilot service implemented during the first pandemic waveNicola Sweeney, Blair Merrick, Rui Pedro Galão, et al.
The Lancet. Microbe|July 6, 2021
Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation studySuzanne Pickering, Rahul Batra, Blair Merrick, et al.
Cell|September 4, 2021
The origins of SARS-CoV-2: A critical reviewEdward C Holmes, Stephen A Goldstein, Angela L Rasmussen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 17, 2021
Combined epidemiological and genomic analysis of nosocomial SARS-CoV-2 infection early in the pandemic and the role of unidentified cases in transmissionLuke B Snell, Chloe L Fisher, Usman Taj, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 16, 2023
The ongoing Streptococcus pyogenes (Group A Streptococcus) outbreak in London, United Kingdom, in December 2022: a molecular epidemiology studyAdela Alcolea-Medina, Luke B Snell, Christopher Alder, et al.
Cell Reports|April 29, 2026
The long isoform of ZAP coordinates multiple enzymes to mediate complete decay of target transcriptsClément R Bouton, Grega Gimpelj Domjanič, María José Lista, et al.
Journal of Virology|November 9, 2022
The P681H Mutation in the Spike Glycoprotein of the Alpha Variant of SARS-CoV-2 Escapes IFITM Restriction and Is Necessary for Type I Interferon ResistanceMaria Jose Lista, Helena Winstone, Harry D Wilson, et al.
Nature Communications|December 31, 2024
Antibodies to the RBD of SARS-CoV-2 spike mediate productive infection of primary human macrophagesSuzanne Pickering, Harry Wilson, Enrico Bravo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2022
Real-Time Whole Genome Sequencing to Guide Patient-Tailored Therapy of Severe Acute Respiratory Syndrome Coronavirus 2 InfectionLuke B Snell, Adela Alcolea-Medina, Themoula Charalampous, et al.
Mbio|June 20, 2019
Upregulation of BST-2 by Type I Interferons Reduces the Capacity of Vpu To Protect HIV-1-Infected Cells from NK Cell ResponsesJérémie Prévost, Suzanne Pickering, Mitchell J Mumby, et al.
Plos One|April 7, 2021
Clinical utility of targeted SARS-CoV-2 serology testing to aid the diagnosis and management of suspected missed, late or post-COVID-19 infection syndromes: Results from a pilot service implemented during the first pandemic waveNicola Sweeney, Blair Merrick, Rui Pedro Galão, et al.
The Lancet. Microbe|July 6, 2021
Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation studySuzanne Pickering, Rahul Batra, Blair Merrick, et al.
Cell|September 4, 2021
The origins of SARS-CoV-2: A critical reviewEdward C Holmes, Stephen A Goldstein, Angela L Rasmussen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 17, 2021
Combined epidemiological and genomic analysis of nosocomial SARS-CoV-2 infection early in the pandemic and the role of unidentified cases in transmissionLuke B Snell, Chloe L Fisher, Usman Taj, et al.
Pageof 8